ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
61.75
-0.25 (-0.40%)
May 14, 2025, 10:34 AM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Generics and Other | 320.03M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rare Disease and Brands | 294.34M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generics, Established Brands, and Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generics, Established Brands, and Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rare Disease | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rare Disease Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generic Pharmaceutical Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generic Pharmaceutical Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Branded Pharmaceutical Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Branded Pharmaceutical Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalties from Licensing Agreements | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalties from Licensing Agreements Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Manufactured Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Manufactured Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product Development Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product Development Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| United States | 604.99M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 24.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 9.39M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|